Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News DiagnaMed Holdings Corp DGNMF


Primary Symbol: C.DMED

DiagnaMed Holdings Corp. is a Canada-based generative artificial intelligence healthcare company. The Company is focused on developing and commercializing CERVAI, a proprietary brain health artificial intelligence (AI) platform. CERVAI leverages generative AI that predicts and monitors brain age and provides actionable insights and tools to diagnose, prevent or improve cognitive decline for... see more

Recent & Breaking News (CSE:DMED)

DiagnaMed's BRAIN AGE® Brain Health AI Platform Accomplishes Clinical Validation Milestone with Peer-Reviewed Paper

GlobeNewswire 7 days ago

DiagnaMed Announces Canadian Launch of BRAIN AGE® Brain Health AI

GlobeNewswire 9 days ago

DiagnaMed Adds New Launch Site of CERVAI(TM) Brain Health AI

GlobeNewswire April 3, 2024

DiagnaMed Announces BRAIN AGE® Trademark Registration Approved by CIPO

GlobeNewswire March 20, 2024

DiagnaMed Strengthening Intellectual Property Support for CERVAI(TM) Brain Health AI Solution

GlobeNewswire March 14, 2024

DiagnaMed Accelerates Commercialization Initiatives of CERVAI(TM) Brain Health AI Solution

GlobeNewswire March 11, 2024

DiagnaMed Announces Test Launch of CERVAI(TM) Brain Health in University Brain Health Center

GlobeNewswire February 28, 2024

DiagnaMed Announces Pilot Launch of CERVAI(TM) Brain Health AI Solution

GlobeNewswire January 17, 2024

DiagnaMed Accelerates Commercialization of CERVAI(TM) Brain Health AI Platform with Acceptance into the SOPHIE Program

GlobeNewswire November 15, 2023

DiagnaMed Launches New Healthcare Provider Network Program for CERVAI(TM) Brain Health AI Platform in Canada and the USA

GlobeNewswire October 3, 2023

DiagnaMed Provides Update for its Brain Health AI Platform, CERVAI(TM)

GlobeNewswire September 13, 2023

DiagnaMed Provides Update on CERVAI(TM), a Brain Health AI Platform Leveraging Generative AI

GlobeNewswire June 20, 2023

Dr. ChatGPT? Meet the new AI medical chatbot

Jonathon Brown June 15, 2023

DiagnaMed Launches a Generative Artificial Intelligence Medical Chatbot, Dr. GenAI

GlobeNewswire June 15, 2023

DiagnaMed Launches PalGPT.ai, a Generative AI Brain Health Solution

GlobeNewswire May 25, 2023

DiagnaMed Announces DTC Eligibility of Its Common Shares in the United States

GlobeNewswire May 17, 2023

DiagnaMed Launches "Health GenAI", a New Division for Generative AI Healthcare Solutions

GlobeNewswire May 10, 2023

DiagnaMed Launches FormGPT.io, a Generative AI Healthcare Solution

GlobeNewswire May 3, 2023

DiagnaMed Announces Listing on OTCQB in the United States

GlobeNewswire April 11, 2023

DiagnaMed Announces Dr. Bassma Ghali as Vice President of Product

GlobeNewswire March 22, 2023